Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusgazalians produced the first 5 billion cubic meters of gas at the Semakovskoye field

8/24/23 GAZP

The NVIDIA announced a quarterly dividend

8/23/23 NVDA

Investments in the new Raspadsky-4 coal block will total more than ₽13 billion

8/23/23 RASP

Ozon plans to re-register from Cyprus to Russia

8/23/23 OZON

Yandex's share in search traffic grew to almost 60%

8/23/23 YNDX

Ozon's turnover in the first half of the year increased almost 2-fold

8/23/23 OZON

Ozon reported for 6 months of 2023

8/23/23 OZON

Ukraine nationalized LSR's gas concrete plants

8/23/23 LSRG

MGTS reported for 6 months by IFRS

8/23/23 MGTS

Atom electric cars will be assembled at the Moskvich plant

8/23/23 KMAZ